Targeting convergent mechanisms of castration resistant prostate cancer therapy resistance, metastasis, and immune evasion with AR-LDDs

Administered By

Medicine, Medical Oncology

Awarded By

Celgene Corporation

Contributors

Armstrong, Andrew John Co Investigator
Somarelli, Jason Andrew Principal Investigator

Start/End

September 3, 2019 - September 2, 2022